✦ LIBER ✦

Sinemet (CR4): an open-label study in moderately severe Parkinson's disease

✍ Scribed by Dr A. MING; J. A. TEMLETT; V. U. FRITZ

Book ID: 114742108
Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 431 KB
Volume: 230
Category: Article
ISSN: 0954-6820
DOI: 10.1111/j.1365-2796.1991.tb00417.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled release levodopa/carbidopa (S

Controlled release levodopa/carbidopa (Sinemet CR4) in Parkinson's disease - an open evaluation of efficacy and safety

✍ Bulling, M.T. ;Wing, L.M.H. ;Burns, R.J. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB

Management of punding in Parkinson’s dis

Management of punding in Parkinson’s disease: an open-label prospective study

✍ A. Fasano; L. Ricciardi; M. Pettorruso; A. R. Bentivoglio 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 141 KB

CQP 201-403 in Parkinson's disease: An o

CQP 201-403 in Parkinson's disease: An open-label pilot study

✍ Dr. Ronald F. Pfeiffer; Leonel H. Herrera; Carolyn S. Glaeske; Ruth E. Hofman 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 1 views

The dopamine agonist, CQP 201-403, was administered to 10 patients in an open label fashion with rapid dosage escalation during hospitalization. Assessed over a n average of 20 days, significant improvement occurred in bradykinesia, rigidity, and postural instability. Tremor did not occur in suffici

Laserlight cues for gait freezing in Par

Laserlight cues for gait freezing in Parkinson’s disease: An open-label study

✍ S. Donovan; C. Lim; N. Diaz; N. Browner; P. Rose; L.R. Sudarsky; D. Tarsy; S. Fa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 251 KB

International (NL-UK) double-blind study

International (NL-UK) double-blind study of Sinemet CR and standard Sinemet (25/100) in 170 patients with fluctuating Parkinson's disease

✍ Erik C. Wolters; H. J. Marleen Tesselaar; F. E. A. M. Bussemaker; J. W. H. H. Da 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 622 KB

Caffeine in Parkinson's disease: A pilot

Caffeine in Parkinson's disease: A pilot open-label, dose-escalation study

✍ Robert D. Altman; Anthony E. Lang; Ronald B. Postuma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 1 views

## Abstract ## Introduction: Epidemiologic studies consistently find an inverse association between caffeine use and PD. Numerous explanations exist, but are difficult to evaluate as caffeine's symptomatic effect and tolerability in PD are unknown. ## Patients and Methods: We designed an open‐la